We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$23.2B
AUM Growth
+$3.33B
Cap. Flow
+$831M
Cap. Flow %
3.59%
Top 10 Hldgs %
15.41%
Holding
2,365
New
77
Increased
1,233
Reduced
966
Closed
81

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$36.9M
2
AMZN icon
Amazon
AMZN
+$32.4M
3
PEP icon
PepsiCo
PEP
+$31.5M
4
META icon
Meta Platforms (Facebook)
META
+$29.6M
5
T icon
AT&T
T
+$26.6M

Sector Composition

Rank Sector Weight
1 Technology 18.4%
2 Financials 15.96%
3 Healthcare 13.51%
4 Consumer Discretionary 10.11%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QIWI
2201
DELISTED
QIWI PLC
QIWI
$156K ﹤0.01%
+10,873
New +$159K
SVM
2202
Silvercorp Metals
SVM
$2.02B
$152K ﹤0.01%
59,498
+21,824
+58% +$52.6K
LTRPA
2203
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$152K ﹤0.01%
10,714
-4,211
-28% -$66.4K
GRPN icon
2204
Groupon
GRPN
$1.03B
$151K ﹤0.01%
2,129
-275
-11% -$19.4K
QUAD icon
2205
Quad
QUAD
$479M
$151K ﹤0.01%
12,686
+901
+8% +$12.1K
ORBC
2206
DELISTED
ORBCOMM, Inc.
ORBC
$148K ﹤0.01%
21,805
+2,166
+11% +$17.3K
FPH icon
2207
Five Point Holdings
FPH
$387M
$146K ﹤0.01%
20,279
-4,987
-20% -$37.5K
SGMO
2208
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$144K ﹤0.01%
15,089
+1,045
+7% +$10.7K
TBBK icon
2209
The Bancorp
TBBK
$2.81B
$138K ﹤0.01%
17,132
+3,961
+30% +$34.3K
RRD
2210
DELISTED
RR Donnelley & Sons Co.
RRD
$138K ﹤0.01%
29,052
+2,669
+10% +$13.8K
BTE icon
2211
Baytex Energy
BTE
$2.96B
$137K ﹤0.01%
80,990
+35,871
+80% +$62.9K
HTT
2212
High Templar Tech Ltd
HTT
$370M
$137K ﹤0.01%
27,051
+2,566
+10% +$13.7K
PGNX
2213
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$137K ﹤0.01%
29,465
-407
-1% -$1.84K
CMO
2214
DELISTED
Capstead Mortgage Corp.
CMO
$136K ﹤0.01%
15,798
-7,126
-31% -$55.8K
ACOR
2215
DELISTED
Acorda Therapeutics
ACOR
$135K ﹤0.01%
85
-8
-9% -$14.4K
PRTA icon
2216
Prothena Corp
PRTA
$448M
$134K ﹤0.01%
+11,056
New +$138K
SPPI
2217
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$134K ﹤0.01%
+12,570
New +$135K
OSUR icon
2218
OraSure Technologies
OSUR
$273M
$133K ﹤0.01%
+11,895
New +$138K
ERF
2219
DELISTED
Enerplus Corporation
ERF
$133K ﹤0.01%
15,843
+1,817
+13% +$15.6K
BBDC icon
2220
Barings BDC
BBDC
$869M
$132K ﹤0.01%
13,422
+573
+4% +$5.6K
SNAP icon
2221
Snap
SNAP
$7.96B
$132K ﹤0.01%
12,012
-1,835
-13% -$15.6K
CORT icon
2222
Corcept Therapeutics
CORT
$9.98B
$131K ﹤0.01%
11,164
-11,708
-51% -$145K
CVIA
2223
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$128K ﹤0.01%
22,985
-11,839
-34% -$61K
VNET
2224
VNET Group
VNET
$1.79B
$125K ﹤0.01%
15,748
-2,504
-14% -$22.4K
ADT icon
2225
ADT
ADT
$5.43B
$123K ﹤0.01%
19,256
-3,801
-16% -$27.4K

Similar funds

Aperio Group's Q1 2019 Portfolio in Review

As of Q1 2019, Aperio Group held 2,365 positions worth $23.2B, up 17% from $19.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aperio Group deployed $831M of net new capital in Q1 2019, opening 77 new positions and adding to 1,233 existing holdings. Its largest new stake was Fox Class A: 279,082 shares worth $10.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was CVS Health, an estimated $25.9M trimmed.

  • Aperio Group's largest Q1 2019 buy was Fox Class A: 279,082 shares worth $10.2M.
  • Aperio Group added most to Walt Disney in Q1 2019, an estimated $36.9M increase.
  • Aperio Group's biggest Q1 2019 reduction was CVS Health, cutting an estimated $25.9M.
  • Aperio Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $38.7M.
  • Aperio Group's ten largest holdings make up 15% of its $23.2B portfolio in Q1 2019.
  • Aperio Group opened 77 new positions and closed 81 in Q1 2019.
  • Aperio Group's portfolio value rose 17% quarter-over-quarter to $23.2B.

Based on Aperio Group's 13F filing for Q1 2019, filed 13 May 2019.